enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Immuneering Reports Third Quarter 2024 Financial Results and ...

    lite.aol.com/tech/story/0022/20241113/9273143.htm

    The September 30, 2024 figure includes $4.2 million of net proceeds from the Company’s ATM facility. Research and Development (R&D) Expenses: R&D expenses for the third quarter of 2024 were $11.3 million, compared with $10.1 million for the third quarter of 2023. The increase in R&D expenses was primarily attributable to higher clinical costs ...

  3. Fluent Announces Third Quarter 2024 Financial Results ...

    lite.aol.com/tech/story/0022/20241114/9274297.htm

    Fluent Announces Third Quarter 2024 Financial Results; Strategic Pivot Accelerates with Growth of Commerce Media Solutions Revenue of $64.5 million for Q3 2024 and $189.2 million for YTD 2024 Commerce Media Solutions revenue grew 341% to $10.4 million (16% of revenue) from $2.3 (3% of revenue) in Q3 last year with gross profit margin of 33% in ...

  4. Canoo Inc. Announces Third Quarter 2024 Results

    lite.aol.com/tech/story/0022/20241113/9273395.htm

    Quarterly cash outflow of $31.3 million in Q3 2024, compared to cash outflow of $39.4 million in Q2, 2024, a 20.7% reduction between Q3 and Q2 2024, and a 58.6% reduction from Q3 2023. Our consolidation of operations from California to Texas and Oklahoma will result in estimated future savings of approximately $12 million - $14 million on an ...

  5. Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript

    www.aol.com/inovio-pharmaceuticals-ino-q3-2024...

    For the third quarter that ended September 30, 2024, our total operating expenses dropped 24%, from $35.9 million in the third quarter of 2023, to $27.3 million in the third quarter of 2024.

  6. Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls

    www.aol.com/novavax-lowers-2024-forecast-despite...

    November 12, 2024 at 8:48 AM. Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls. On Tuesday, Novavax Inc (NASDAQ: NVAX) reported third-quarter 2024 sales of $84.5 million, compared ...

  7. PubMatic (PUBM) Q3 2024 Earnings Call Transcript - AOL

    www.aol.com/pubmatic-pubm-q3-2024-earnings...

    *Stock Advisor returns as of November 11, 2024. ... including our most recent Form 10-K and any subsequent filings on Forms 10-Q or 8-K. ... We estimate a 10% to 15% increase in engineering ...

  8. London Underground 2024 Stock - Wikipedia

    en.wikipedia.org/wiki/London_Underground_2024_Stock

    The London Underground 2024 Stock, known as the New Tube for London (NTfL) during development, is a London Underground train being built by Siemens Mobility at its facilities in Goole, United Kingdom and Vienna, Austria. It is part of the Siemens Inspiro family of metro and rapid-transport trains. An initial batch of 94 nine-car trains has been ...

  9. First Advantage Reports Third Quarter 2024 Results

    lite.aol.com/tech/story/0022/20241112/9271600.htm

    Issuing combined company full-year 2024 guidance, including the impacts of Sterling results for November and December 2024, including the benefits of actioned synergies and the estimated capital structure impacts of the transaction, with ranges for Revenues of $858 million to $918 million, Adjusted EBITDA of $250 million to $274 million ...